143 related articles for article (PubMed ID: 16507381)
21. Assessment of the palatability of antistaphylococcal antibiotics in pediatric volunteers.
Matsui D; Barron A; Rieder MJ
Ann Pharmacother; 1996 Jun; 30(6):586-8. PubMed ID: 8792942
[TBL] [Abstract][Full Text] [Related]
22. Patient stratification in the management of acute bacterial exacerbation of chronic bronchitis: the role of levofloxacin 750 mg.
Martinez FJ; Grossman RF; Zadeikis N; Fisher AC; Walker K; Ambruzs ME; Tennenberg AM
Eur Respir J; 2005 Jun; 25(6):1001-10. PubMed ID: 15929954
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of cefdinir in the treatment of maxillary sinusitis.
Steurer M; Schenk P
Eur Arch Otorhinolaryngol; 2000; 257(3):140-8. PubMed ID: 10839487
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and tolerability of cefprozil versus amoxicillin/clavulanate for the treatment of adults with severe sinusitis.
Adelglass J; Bundy JM; Woods R
Clin Ther; 1998; 20(6):1115-29. PubMed ID: 9916606
[TBL] [Abstract][Full Text] [Related]
25. Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children.
Kogan R; Martínez MA; Rubilar L; Payá E; Quevedo I; Puppo H; Girardi G; Castro-Rodriguez JA
Pediatr Pulmonol; 2003 Feb; 35(2):91-8. PubMed ID: 12526069
[TBL] [Abstract][Full Text] [Related]
26. Antimicrobial drug suspensions: a blinded comparison of taste of twelve common pediatric drugs including cefixime, cefpodoxime, cefprozil and loracarbef.
Demers DM; Chan DS; Bass JW
Pediatr Infect Dis J; 1994 Feb; 13(2):87-9. PubMed ID: 8190556
[TBL] [Abstract][Full Text] [Related]
27. Human serum activity of telithromycin, azithromycin and amoxicillin/clavulanate against common aerobic and anaerobic respiratory pathogens.
Stein GE; Schooley S; Tyrrell KL; Citron DM; Goldstein EJ
Int J Antimicrob Agents; 2007 Jan; 29(1):39-43. PubMed ID: 17189093
[TBL] [Abstract][Full Text] [Related]
28. Efficacy, safety and tolerability of 3 day azithromycin versus 10 day co-amoxiclav in the treatment of children with acute lower respiratory tract infections.
Ferwerda A; Moll HA; Hop WC; Kouwenberg JM; Tjon Pian Gi CV; Robben SG; de Groot R
J Antimicrob Chemother; 2001 Apr; 47(4):441-6. PubMed ID: 11266417
[TBL] [Abstract][Full Text] [Related]
29. Review of the spectrum and potency of orally administered cephalosporins and amoxicillin/clavulanate.
Sader HS; Jacobs MR; Fritsche TR
Diagn Microbiol Infect Dis; 2007 Mar; 57(3 Suppl):5S-12S. PubMed ID: 17292577
[TBL] [Abstract][Full Text] [Related]
30. A randomized comparative study of levofloxacin versus amoxicillin/clavulanate for treatment of infants and young children with recurrent or persistent acute otitis media.
Noel GJ; Blumer JL; Pichichero ME; Hedrick JA; Schwartz RH; Balis DA; Melkote R; Bagchi P; Arguedas A
Pediatr Infect Dis J; 2008 Jun; 27(6):483-9. PubMed ID: 18449063
[TBL] [Abstract][Full Text] [Related]
31. An open, multicentre, comparative study of the efficacy and safety of azithromycin and co-amoxiclav in the treatment of upper and lower respiratory tract infections in children. The Paediatric Azithromycin Study Group.
Lauvau DV; Verbist L
J Int Med Res; 1997; 25(5):285-95. PubMed ID: 9364291
[TBL] [Abstract][Full Text] [Related]
32. A pooled comparison of cefdinir and penicillin in the treatment of group a beta-hemolytic streptococcal pharyngotonsillitis.
Brook I
Clin Ther; 2005 Aug; 27(8):1266-73. PubMed ID: 16199251
[TBL] [Abstract][Full Text] [Related]
33. Twice-daily antibiotics in the treatment of acute otitis media: trimethoprim-sulfamethoxazole versus amoxicillin-clavulanate.
Feldman W; Sutcliffe T; Dulberg C
CMAJ; 1990 Jan; 142(2):115-8. PubMed ID: 2403833
[TBL] [Abstract][Full Text] [Related]
34. Assessment of the palatability of beta-lactamase-resistant antibiotics in children.
Matsui D; Lim R; Tschen T; Rieder MJ
Arch Pediatr Adolesc Med; 1997 Jun; 151(6):599-602. PubMed ID: 9193246
[TBL] [Abstract][Full Text] [Related]
35. Antimicrobial liquid formulations: a blind taste comparison of three brands of penicillin VK and three brands of amoxicillin.
Chan DS; Demers DM; Bass JW
Ann Pharmacother; 1996 Feb; 30(2):130-2. PubMed ID: 8835043
[TBL] [Abstract][Full Text] [Related]
36. Treatment Failure and Adverse Events After Amoxicillin-Clavulanate vs Amoxicillin for Pediatric Acute Sinusitis.
Savage TJ; Kronman MP; Sreedhara SK; Lee SB; Oduol T; Huybrechts KF
JAMA; 2023 Sep; 330(11):1064-1073. PubMed ID: 37721610
[TBL] [Abstract][Full Text] [Related]
37. Topical ciprofloxacin/dexamethasone superior to oral amoxicillin/clavulanic acid in acute otitis media with otorrhea through tympanostomy tubes.
Dohar J; Giles W; Roland P; Bikhazi N; Carroll S; Moe R; Reese B; Dupre S; Wall M; Stroman D; McLean C; Crenshaw K
Pediatrics; 2006 Sep; 118(3):e561-9. PubMed ID: 16880248
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of pharmacokinetically enhanced amoxicillin-clavulanate at 2,000/125 milligrams twice daily for 5 days versus amoxicillin-clavulanate at 875/125 milligrams twice daily for 7 days in the treatment of acute exacerbations of chronic bronchitis.
Sethi S; Breton J; Wynne B
Antimicrob Agents Chemother; 2005 Jan; 49(1):153-60. PubMed ID: 15616290
[TBL] [Abstract][Full Text] [Related]
39. Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial.
Hooton TM; Scholes D; Gupta K; Stapleton AE; Roberts PL; Stamm WE
JAMA; 2005 Feb; 293(8):949-55. PubMed ID: 15728165
[TBL] [Abstract][Full Text] [Related]
40. Antimicrobial drug suspensions: a blind comparison of taste of fourteen common pediatric drugs.
Ruff ME; Schotik DA; Bass JW; Vincent JM
Pediatr Infect Dis J; 1991 Jan; 10(1):30-3. PubMed ID: 2003053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
